The Lymphoma Channel is supported with funding from AstraZeneca (Diamond), BMS (Gold), Johnson & Johnson (Gold), Takeda (Silver) and Galapagos (Bronze).
The Multiple Myeloma Channel is supported with funding from BMS (Gold) and Legend Biotech (Bronze).
VJHemOnc is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
COSTEM | COSTEM 2021: highlights from day one
Arnon Nagler, MD, Chaim Sheba Medical Center, Tel-Aviv, Israel, discusses highlights from day one of the COSTEM 2021 meeting, highlighting progress in the haploidentical transplant setting, in the treatment of chronic graft-versus-host disease (GvHD), and in the use of immunotherapies. This interview took place at the 6th Congress on Controversies in Stem Cell Transplantation and Cellular Therapies (COSTEM), which took place virtually.
